Status:
UNKNOWN
Comparison Between Efficacy of Daily and Intermittent Low Glycemic Index Therapy Diet
Lead Sponsor:
All India Institute of Medical Sciences
Conditions:
Drug Resistant Epilepsy
Eligibility:
All Genders
1-15 years
Phase:
NA
Brief Summary
Drug resistant epilepsy constitutes about one third of all children diagnosed with epilepsy. Although ketogenic diet is being used for drug resistant epilepsy for almost hundred years, its restrictive...
Detailed Description
Drug resistant epilepsy constitutes about one third of all children diagnosed with epilepsy. Although ketogenic diet is being used for drug resistant epilepsy for almost hundred years, its restrictive...
Eligibility Criteria
Inclusion
- Children aged 1-15 years with drug resistant epilepsy
- Willing to come for regular follow up
Exclusion
- Surgically remediable cause for drug resistant epilepsy
- Proven in born error of metabolism except in which dietary therapy for epilepsy is indicated(i.e. pyruvate carboxylase deficiency and GLUT 1 deficiency)
- Previously received KD, MAD or LGIT
- Known case of
- Chronic kidney disease
- Chronic liver disease/GI illness
- Chronic heart disease(congenital and acquired)
- Chronic respiratory illness
Key Trial Info
Start Date :
February 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03464487
Start Date
February 15 2018
End Date
January 1 2019
Last Update
March 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AIIMS
New Delhi, National Capital Territory of Delhi, India